ArticleInfection and drug resistance2026
Prolonged Thromboelastography R Time and Thrombocytopenia as Early Warning Indicators of Bleeding in ECMO Patients Who Developed Sepsis During Support: A Retrospective Cohort Study.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Prognostic Performance of SOFA2.0 and SOFA for 28-Day Mortality in Patients Developing Sepsis During ECMO Support.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Bleeding is a major complication in extracorporeal membrane oxygenation (ECMO), particularly when sepsis develops during support. Conventional coagulation tests incompletely reflect haemostatic balance, and reliable early indicators of bleeding risk remain lacking. This study investigated whether dynamic changes in thromboelastography (TEG) parameters and platelet count are associated with subsequent bleeding in this population. Methods: We conducted a single-center retrospective cohort study including adult patients who developed sepsis during ECMO support between January 2021 and December 2024. Coagulation parameters were recorded at sepsis onset and within 24 hours prior to bleeding events. Major bleeding was defined according to Extracorporeal Life Support Organization criteria. A matched longitudinal analysis was additionally performed in the non-bleeding group using Day 4 after sepsis onset as a comparable observation window. Temporal changes were analyzed using paired statistical tests. Results: Sixty-four patients were included, of whom 26 (40.6%) developed major bleeding. In the bleeding group, R-time significantly prolonged prior to bleeding compared with sepsis onset (10.1 vs 7.5 min, P = 0.03), while platelet count significantly decreased (93.5 vs 110.0 ×10 Conclusion: In ECMO patients who develop sepsis, coordinated prolongation of TEG R-time and decline in platelet count precede bleeding events and may represent early warning indicators associated with bleeding risk. These findings are hypothesis-generating and require confirmation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.